Switch to:
More From Other Websites
Merck Gets FDA Approval for Investigational Drug Zinplava Oct 24 2016
Top Health Care Earnings Coming Next Week Oct 23 2016
Alkermes Depression Candidate Positive in Phase III Study Oct 21 2016
BioMarin Could Reap $1.1 Billion In 2025 On 'Dwarfism' Drug: Analyst Oct 20 2016
A Look At The Science Behind BioMarin Pharmaceutical Inc. (BMRN)’s Next Pivotal Candidate Oct 20 2016
What's in Store for BioMarin (BMRN) This Earnings Season? Oct 20 2016
BioMarin Presents Vosoritide Data in Achondroplasia at American Society of Human Genetics (ASHG)... Oct 19 2016
How Much Return Could Alexion Offer over the Next 12 months? Oct 19 2016
AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted Oct 19 2016
The Medicines Co. Reports Positive Phase II Data on PCSK9si Oct 19 2016
Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia Oct 18 2016
Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $5.6 million of Shares Oct 17 2016
Allergan's Belkyra Gets Swedish Approval for Double Chin Oct 17 2016
Bristol-Myers Wins CHMP Nod for Opdivo Label Expansion Oct 17 2016
PTC Therapeutics Getting Cold Shoulder From Regulators on Duchenne Drug Appeal Oct 17 2016
BioMarin Issues Encouraging Update on Hemophilia A Drug Oct 14 2016
Sunesis Submits Response to Questions on Leukemia Drug Oct 14 2016
OncoGenex Cancer Drug Fails in Phase III Study, Stock Down Oct 14 2016
UK Regulatory Agency Approves Continued Enrollment in BioMarin Phase 1/2 Study of BMN 270 in... Oct 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)